The GLP-1 revolution: Is India ready for the next era of obesity treatment?
In late 2025, a weekly injectable drug that most Indians had never heard of a year earlier overtook a decades-old […]
×
GLP-1-DRUGS-INDIA
Eli Lilly Becomes First Healthcare Company Globally to Cross $1 Trillion Market Cap, Driven by Explosive GLP-1 Growth
In a landmark moment for the global pharmaceutical industry, Eli Lilly & Co. has officially crossed the $1 trillion market […]
